ENHANCING T-CELL IMMUNOTHERAPY TO TREAT PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS

$708,546FY2021Defense Health AgencyDOD

Children'S Research Institute, Washington DC

Investigators

ENHANCING T-CELL IMMUNOTHERAPY TO TREAT PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS · GrantIndex